Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Cartron, Guillaume
[Clear All Filters]
2024
Stathis A
,
Pirosa MCristina
,
Orsucci L
,
Feugier P
,
Tani M
,
Ghesquières H
,
Musuraca G
,
Rossi FGaia
,
Merli F
,
Guieze R
, et al.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica. 2024.
PubMed
Google Scholar
2023
Gonzalez-Menendez P
,
Phadke I
,
Olive ME
,
Joly A
,
Papoin J
,
Yan H
,
Galtier J
,
Platon J
,
Kang SWoo Sophie
,
McGraw KL
, et al.
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A.
Blood. 2023.
PubMed
Google Scholar
Houot R
,
Bachy E
,
Cartron G
,
Gros F-X
,
Morschhauser F
,
Obéric L
,
Gastinne T
,
Feugier P
,
Duléry R
,
Thieblemont C
, et al.
Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial.
Nat Med. 2023.
PubMed
Google Scholar
Houot R
,
Bachy E
,
Cartron G
,
Gros F-X
,
Morschhauser F
,
Obéric L
,
Gastinne T
,
Feugier P
,
Duléry R
,
Thieblemont C
, et al.
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nat Med. 2023.
PubMed
Google Scholar
2021
Ghesquières H
,
Dalban C
,
Nicolas-Virelizier E
,
Jardin F
,
Le Bras F
,
Le Gouill S
,
Casasnovas O
,
Vizoso S
,
Hernandez C
,
Metzger S
, et al.
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres.
Br J Haematol. 2021.
PubMed
Google Scholar
Rodgers TD
,
Casulo C
,
Boissard F
,
Launonen A
,
Parreira J
,
Cartron G
.
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
Oncol Ther. 2021.
PubMed
Google Scholar
2014
Touzeau C
,
Leux C
,
Bouabdallah R
,
Roussel M
,
Delarue R
,
Bouabdallah K
,
Thieblemont C
,
Cacheux V
,
Cartron G
,
Compain L
, et al.
Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.
Ann Hematol. 2014;93(2):233-42.
PubMed
Google Scholar